Cargando…

SEOM Clinical Guideline in ovarian cancer (2016)

Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer (OC) is the first cause of death due to gynecological cancer and the fifth cause of death for cancer in women in Spain. The aim of this guideline is to summarize the current evidence and to give evidence-...

Descripción completa

Detalles Bibliográficos
Autores principales: Santaballa, A., Barretina, P., Casado, A., García, Y., González-Martín, A., Guerra, E., Laínez, N., Martinez, J., Redondo, A., Romero, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138249/
https://www.ncbi.nlm.nih.gov/pubmed/27905052
http://dx.doi.org/10.1007/s12094-016-1588-8
_version_ 1782472031880609792
author Santaballa, A.
Barretina, P.
Casado, A.
García, Y.
González-Martín, A.
Guerra, E.
Laínez, N.
Martinez, J.
Redondo, A.
Romero, I.
author_facet Santaballa, A.
Barretina, P.
Casado, A.
García, Y.
González-Martín, A.
Guerra, E.
Laínez, N.
Martinez, J.
Redondo, A.
Romero, I.
author_sort Santaballa, A.
collection PubMed
description Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer (OC) is the first cause of death due to gynecological cancer and the fifth cause of death for cancer in women in Spain. The aim of this guideline is to summarize the current evidence and to give evidence-based recommendations for clinical practice.
format Online
Article
Text
id pubmed-5138249
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-51382492016-12-21 SEOM Clinical Guideline in ovarian cancer (2016) Santaballa, A. Barretina, P. Casado, A. García, Y. González-Martín, A. Guerra, E. Laínez, N. Martinez, J. Redondo, A. Romero, I. Clin Transl Oncol Clinical Guides in Oncology Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer (OC) is the first cause of death due to gynecological cancer and the fifth cause of death for cancer in women in Spain. The aim of this guideline is to summarize the current evidence and to give evidence-based recommendations for clinical practice. Springer International Publishing 2016-11-30 2016 /pmc/articles/PMC5138249/ /pubmed/27905052 http://dx.doi.org/10.1007/s12094-016-1588-8 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Guides in Oncology
Santaballa, A.
Barretina, P.
Casado, A.
García, Y.
González-Martín, A.
Guerra, E.
Laínez, N.
Martinez, J.
Redondo, A.
Romero, I.
SEOM Clinical Guideline in ovarian cancer (2016)
title SEOM Clinical Guideline in ovarian cancer (2016)
title_full SEOM Clinical Guideline in ovarian cancer (2016)
title_fullStr SEOM Clinical Guideline in ovarian cancer (2016)
title_full_unstemmed SEOM Clinical Guideline in ovarian cancer (2016)
title_short SEOM Clinical Guideline in ovarian cancer (2016)
title_sort seom clinical guideline in ovarian cancer (2016)
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138249/
https://www.ncbi.nlm.nih.gov/pubmed/27905052
http://dx.doi.org/10.1007/s12094-016-1588-8
work_keys_str_mv AT santaballaa seomclinicalguidelineinovariancancer2016
AT barretinap seomclinicalguidelineinovariancancer2016
AT casadoa seomclinicalguidelineinovariancancer2016
AT garciay seomclinicalguidelineinovariancancer2016
AT gonzalezmartina seomclinicalguidelineinovariancancer2016
AT guerrae seomclinicalguidelineinovariancancer2016
AT lainezn seomclinicalguidelineinovariancancer2016
AT martinezj seomclinicalguidelineinovariancancer2016
AT redondoa seomclinicalguidelineinovariancancer2016
AT romeroi seomclinicalguidelineinovariancancer2016